Revelation Partners

Arbor Biotechnologies, Inc., founded in 2016 and headquartered in Cambridge, Massachusetts, operates as a bio-discovery company in the biotechnology sector. The company focuses on developing genomic tools that enhance human health and sustainability. Utilizing a combination of artificial intelligence, genome sequencing, gene synthesis, and high-throughput screening, Arbor's platform accelerates the discovery of proteins and facilitates human diagnostic development. The technology aggregates genomic sequence data through AI and machine learning, enabling drug developers to replace entire genes and precisely correct mutations. This approach aims to streamline the development of curative treatments for previously incurable genetic diseases, ultimately improving the lives of patients affected by such conditions.

VitalConnect is a company that specializes in wearable biosensor technology for wireless patient monitoring. It develops innovative solutions that enable continuous monitoring and recording of patients' vital signs through an adhesive patch applied to the body. The technology integrates expertise in biomedical engineering, data analytics, and chip design, allowing vital data to be displayed on mobile devices and computer systems. This capability empowers healthcare professionals to respond promptly to urgent situations and gain valuable insights into patient health, facilitating informed decision-making in both inpatient and outpatient settings, including hospital monitoring, post-discharge care, and cardiac monitoring.

SPR Therapeutics, LLC is a medical device company based in Cleveland, Ohio, specializing in the development and commercialization of interventional pain management therapies. The company focuses on peripheral nerve stimulation (PNS) systems, with its flagship product being the Smartpatch, a minimally invasive device designed to deliver short-term therapy for pain relief. This system is effective for various types of pain, including post-surgical discomfort following procedures like knee replacements and thoracotomies, as well as neuropathic and musculoskeletal pain. In addition to the Smartpatch, SPR Therapeutics offers the Micropulse, an implantable PNS system for long-term therapy, and the Smartpatch MicroLead, which promotes rapid tissue ingrowth. By providing non-narcotic alternatives for pain management, SPR Therapeutics aims to offer safe and effective treatments that reduce reliance on opioid medications and invasive surgeries. The company was founded in 2009 and has additional facilities in the Carolina’s Research Triangle and Minneapolis, Minnesota.

Nouscom is a biotechnology company focused on developing an immunotherapy platform that creates engineered viral vector vaccines for cancer treatment. The company's innovative platform leverages a portfolio of modified viral vectors, specifically designed for the efficient expression of long strings of tumor neoantigens. This approach is complemented by a toolkit that facilitates the induction of robust antitumor T-cell responses, effectively enhancing cancer-specific cellular immunity in patients. Through its research and development efforts, Nouscom aims to improve cancer treatment outcomes by harnessing the body's immune system to target and combat cancer cells.

VitalConnect is a company that specializes in wearable biosensor technology for wireless patient monitoring. It develops innovative solutions that enable continuous monitoring and recording of patients' vital signs through an adhesive patch applied to the body. The technology integrates expertise in biomedical engineering, data analytics, and chip design, allowing vital data to be displayed on mobile devices and computer systems. This capability empowers healthcare professionals to respond promptly to urgent situations and gain valuable insights into patient health, facilitating informed decision-making in both inpatient and outpatient settings, including hospital monitoring, post-discharge care, and cardiac monitoring.

Carrum Health is an online healthcare platform focused on simplifying the healthcare payment model for employers and their employees. By establishing direct connections between progressive self-insured employers and top-quality regional healthcare providers, Carrum Health offers a comprehensive bundled payment solution that enhances the value of health benefits. The platform aims to reduce healthcare costs for patients, often leading to low or zero out-of-pocket expenses. Through this innovative approach, Carrum Health seeks to streamline the delivery and financing of healthcare, making it more accessible and affordable for both employers and their workforce.

Vedanta Biosciences, Inc. is a clinical-stage microbiome company based in Cambridge, Massachusetts, focusing on the development of therapies for immune-mediated diseases. Established in 2010, the company specializes in creating immunotherapies utilizing human microbiome-derived bacteria. Its innovative platform includes a collection of defined bacterial consortia, proprietary assays for selecting effective strains, and extensive datasets from human interventional studies. Vedanta Biosciences also possesses capabilities for cGMP-compliant manufacturing, allowing for the production of live bacterial therapies in powder form. This enables healthcare providers to administer oral treatments aimed at addressing autoimmune and inflammatory diseases efficiently, potentially pioneering a new category of therapies based on the human microbiome.

Bristol Hospice, established in 2006, specializes in delivering hospice and palliative care services to patients, families, and communities. The organization focuses on promoting quality and comprehensive care tailored to the needs of those it serves. Its offerings include nursing, physician services, home health aides, counseling, spiritual support, therapy, dietary assistance, and bereavement services. Additionally, Bristol Hospice provides durable medical equipment and supplies, ensuring that customers receive support for their physical, psychosocial, and spiritual needs. Through its strategic planning, the company aims to enhance the quality of life for individuals facing serious illnesses.

Carrick Therapeutics, Ltd. is a Dublin-based company founded in 2015 that specializes in the development of innovative cancer therapeutics. The company focuses on targeting molecular pathways associated with aggressive and resistant forms of cancer. By employing advanced mechanisms, Carrick Therapeutics aims to transform cancer treatment and improve patient outcomes. Their approach facilitates the early detection of predictive biomarkers, allowing for timely initiation of personalized treatments.

Syapse, Inc. is a technology company that specializes in precision medicine through its innovative software platform, which aggregates and analyzes clinical, molecular, treatment, and outcomes data. Founded in 2008 and headquartered in San Francisco, California, with an additional office in Radnor, Pennsylvania, Syapse aims to enhance healthcare by providing actionable insights that support data-driven decision-making in precision oncology. The company operates the Syapse Learning Health Network, a global network that enables health systems and life sciences collaborators to share real-world cancer data. This network empowers healthcare organizations to collaborate effectively, ensuring that oncologists and decision-makers have access to comprehensive patient insights at the point of care, ultimately driving improved outcomes for cancer patients. Syapse has established strategic partnerships, including a collaboration with Pfizer, to further its mission of delivering personalized care based on robust real-world evidence.

Dren Bio is a biotechnology company that specializes in protein engineering technologies aimed at depleting pathogenic cells, protein aggregates, and other disease-causing agents. The company operates under a holding business model, developing a diverse portfolio of projects that function as stand-alone assets. Dren Bio's platform is designed to address a range of health conditions, including hematologic neoplasms, solid tumors, autoimmune disorders, and diseases associated with protein aggregation. By focusing on innovative protein-based technologies, Dren Bio enables healthcare professionals to manage and treat various serious diseases more effectively.

Aspen Neuroscience, Inc. is a biotechnology company based in San Diego, California, focused on developing innovative therapies for neurological conditions, particularly Parkinson's disease. Founded in 2018, the company specializes in induced pluripotent stem cells (iPSCs) to create patient-specific cell therapies. Its product pipeline includes ANPD001, an autologous neuron replacement therapy for sporadic Parkinson's disease, and ANPD002, a gene-edited version targeting familial forms of the disease. By combining genomic approaches with stem cell biology, Aspen Neuroscience aims to address significant unmet medical needs and modify the progression of Parkinson's disease through personalized and restorative treatments.

Iris Telehealth is a prominent provider of telepsychiatry services in the United States, catering to community mental health centers, community health centers, hospitals, and health systems. The company specializes in connecting these facilities with qualified mental health professionals through secure videoconferencing technology. This approach allows patients to receive essential mental health care without the need for travel, thereby enhancing access to services. By facilitating remote consultations, Iris Telehealth aims to improve patient outcomes and support clinicians in delivering high-quality care, while also generating financial benefits for healthcare providers.

IntelyCare, Inc. is a healthcare staffing solutions company based in Quincy, Massachusetts, founded in 2014. It provides an advanced digital workforce augmentation platform that combines a gig-model application with data science to address staffing challenges in the healthcare sector. The platform allows post-acute healthcare facilities to optimize their staffing levels by matching nursing professionals with available shifts, thereby filling positions at a rate significantly higher than the industry average. It also empowers nurses and nursing assistants to create flexible schedules and choose their preferred shifts, helping to reduce burnout and improve retention rates. In addition, IntelyCare's platform incorporates artificial intelligence to automate scheduling and manage staffing needs efficiently, while also ensuring that healthcare providers can verify the licensure status of nursing staff easily. The company serves a diverse range of clients, including nurses, home care agencies, assisted living facilities, long-term care institutions, and rehabilitation hospitals.

Gravie, Inc. is a health insurance platform based in Minneapolis, Minnesota, that provides health insurance plans for individuals, families, and employers. Established in 2013, Gravie enables users to compare insurance options available through government-run marketplaces as well as directly from insurance companies. The company specializes in designing tailored benefits plans for employees, managing payments, and offering year-round support. Its services include Gravie Care, which allows individuals to shop for their benefits, and it utilizes a mobile application and website for ease of access. Gravie's innovative approach includes a defined contribution model, allowing employers to set fixed annual budgets for health benefits while providing tools for effective cost management. The platform also facilitates a better understanding of healthcare expenses through detailed price comparisons and information on co-pays, co-insurance, and applicable tax credits.

Gravie, Inc. is a health insurance platform based in Minneapolis, Minnesota, that provides health insurance plans for individuals, families, and employers. Established in 2013, Gravie enables users to compare insurance options available through government-run marketplaces as well as directly from insurance companies. The company specializes in designing tailored benefits plans for employees, managing payments, and offering year-round support. Its services include Gravie Care, which allows individuals to shop for their benefits, and it utilizes a mobile application and website for ease of access. Gravie's innovative approach includes a defined contribution model, allowing employers to set fixed annual budgets for health benefits while providing tools for effective cost management. The platform also facilitates a better understanding of healthcare expenses through detailed price comparisons and information on co-pays, co-insurance, and applicable tax credits.

Omada Health, Inc. is a digital healthcare company that specializes in developing online programs aimed at managing chronic conditions. Founded in 2011 and headquartered in San Francisco, California, with an additional office in Atlanta, Georgia, Omada focuses on preventing conditions such as prediabetes, diabetes, hypertension, and heart disease. The company provides personalized digital health programs that cater to the unique needs of individuals, utilizing professional health coaching, connected health devices, and real-time data to facilitate meaningful health improvements. Omada is recognized as the largest provider of the National Diabetes Prevention Program, empowering individuals to engage actively in their health and achieve sustainable lifestyle changes. The platform also addresses behavioral health issues, including anxiety and depression, further supporting individuals in their overall wellness journey.

Endeavor BioMedicines is a clinical-stage company based in Solana Beach, California, founded in 2018. The company is dedicated to developing innovative treatments that address the underlying causes of pulmonary fibrosis, particularly idiopathic pulmonary fibrosis (IPF). Endeavor BioMedicines is focused on creating a small-molecule inhibitor that has the potential to not only halt the progression of IPF but also to reverse its effects. By concentrating on these advancements, the company aims to enable healthcare professionals to provide more precise treatments for terminal conditions, ultimately improving patient outcomes and enhancing quality of life.

Verana Health, Inc. is a digital health company based in San Francisco, California, that specializes in transforming healthcare data into actionable insights. Founded in 2008 and formerly known as Digisight Technologies, the company connects healthcare providers with patients through innovative solutions. Its flagship product, SightBook, is a mobile application that enables users to test their vision and share results with their physicians in real-time, facilitating timely appointments and treatments. Verana Health manages data from over 20,000 healthcare providers and 70 electronic health record systems, leveraging its AI-enhanced platform, VeraQ™, to create a robust healthcare data ecosystem. By utilizing advanced analytics on curated datasets, Verana Health supports life sciences partners in improving clinical research and enhancing patient care outcomes.

HotSpot Therapeutics is a biotechnology startup based in Boston, Massachusetts, established in 2017. The company specializes in the development of allosteric therapies that target regulatory sites on proteins. Its innovative therapeutic platform is designed to identify hotspots and locate pathway treatments for cancer, metabolic disorders, and rare diseases. By leveraging a comprehensive database of hotspot structures and utilizing data science, HotSpot Therapeutics employs a multidisciplinary approach to drug discovery. This approach aims to enhance the effectiveness of treatments and improve patient outcomes across a range of conditions.

Click Therapeutics, Inc. is a New York-based company that specializes in the engineering, validation, development, and commercialization of digital therapeutics aimed at addressing unmet medical needs through cognitive and neurobehavioral modification. Founded in 2012, Click Therapeutics focuses on creating software-based medical treatments for various conditions, including smoking cessation, major depressive disorders, schizophrenia, insomnia, and chronic pain. Its innovative Digital Therapeutics™ can be utilized independently or alongside traditional biomedical treatments, enhancing patient engagement and treatment outcomes. The company's Clickometrics® adaptive data science platform personalizes user experiences to optimize results. Notably, Click's smoking cessation program has successfully launched nationwide, and its leading prescription program is currently undergoing a phase III FDA registration trial for treating Major Depressive Disorder in adults.

SPR Therapeutics, LLC is a medical device company based in Cleveland, Ohio, specializing in the development and commercialization of interventional pain management therapies. The company focuses on peripheral nerve stimulation (PNS) systems, with its flagship product being the Smartpatch, a minimally invasive device designed to deliver short-term therapy for pain relief. This system is effective for various types of pain, including post-surgical discomfort following procedures like knee replacements and thoracotomies, as well as neuropathic and musculoskeletal pain. In addition to the Smartpatch, SPR Therapeutics offers the Micropulse, an implantable PNS system for long-term therapy, and the Smartpatch MicroLead, which promotes rapid tissue ingrowth. By providing non-narcotic alternatives for pain management, SPR Therapeutics aims to offer safe and effective treatments that reduce reliance on opioid medications and invasive surgeries. The company was founded in 2009 and has additional facilities in the Carolina’s Research Triangle and Minneapolis, Minnesota.

Honor is a leading senior care network and technology platform that focuses on enhancing the quality of life for older adults and their families. Founded in 2014 by Cameron Ring, Monica Lo, Sandy Jen, and Seth Sternberg in San Francisco, California, Honor has established itself as a pioneer in the home care industry. The company offers expert in-home care services for seniors, leveraging an integrated system of third-party care providers. By combining scalable workforce management with personalized care, Honor enables older adults to live safely and comfortably in their own homes. In 2021, Honor expanded its reach by acquiring Home Instead, enhancing its capabilities through a global network and a relationship-based care model. This strategic move positions Honor to address the evolving needs of aging adults and professional caregivers worldwide.

US Fertility is a physician-owned and physician-led practice management firm specializing in the fertility sector across the United States. The company provides a comprehensive suite of business support services to top-tier fertility programs, focusing on enhancing operational efficiency and patient care. By leveraging advanced technology platforms, US Fertility effectively manages clinical and business information systems, as well as other essential functions such as finance, legal, and lab operations. Their commitment to innovation and best practices aims to improve treatment outcomes and the overall patient experience. With a strong emphasis on collaboration, US Fertility supports both domestic and international fertility practices, ensuring they can deliver exceptional care to their patients.

Genome Medical, Inc. is a genomic medicine delivery company based in South San Francisco, California, established in 2016. It operates a technology platform known as Genome Care Delivery, which connects individuals and healthcare providers with genetic specialists to facilitate virtual genetic consultations. The company focuses on various areas of clinical care, including cancer, cardiovascular health, reproductive health, pediatrics, and pharmacogenomics. By providing expert genetic assessments and personalized clinical action plans, Genome Medical helps patients understand their genetic risks and make informed treatment decisions. Additionally, the company supports healthcare providers in navigating the growing field of genetics, enhancing disease diagnosis, and improving patient care while aiming to reduce overall healthcare costs.

Singular Genomics is a life science technology company that develops innovative sequencing platforms. Its core product, the Singular Sequencing Engine, powers two integrated solutions: G4 for next-generation sequencing (NGS) markets, offering high accuracy and speed; and PX, which combines single-cell analysis, spatial analysis, genomics, and proteomics in one versatile multi-omics instrument. These products aim to empower researchers and clinicians across diverse fields such as basic biology, oncology, immunology, and more.

Gravie, Inc. is a health insurance platform based in Minneapolis, Minnesota, that provides health insurance plans for individuals, families, and employers. Established in 2013, Gravie enables users to compare insurance options available through government-run marketplaces as well as directly from insurance companies. The company specializes in designing tailored benefits plans for employees, managing payments, and offering year-round support. Its services include Gravie Care, which allows individuals to shop for their benefits, and it utilizes a mobile application and website for ease of access. Gravie's innovative approach includes a defined contribution model, allowing employers to set fixed annual budgets for health benefits while providing tools for effective cost management. The platform also facilitates a better understanding of healthcare expenses through detailed price comparisons and information on co-pays, co-insurance, and applicable tax credits.

Gravie, Inc. is a health insurance platform based in Minneapolis, Minnesota, that provides health insurance plans for individuals, families, and employers. Established in 2013, Gravie enables users to compare insurance options available through government-run marketplaces as well as directly from insurance companies. The company specializes in designing tailored benefits plans for employees, managing payments, and offering year-round support. Its services include Gravie Care, which allows individuals to shop for their benefits, and it utilizes a mobile application and website for ease of access. Gravie's innovative approach includes a defined contribution model, allowing employers to set fixed annual budgets for health benefits while providing tools for effective cost management. The platform also facilitates a better understanding of healthcare expenses through detailed price comparisons and information on co-pays, co-insurance, and applicable tax credits.

Nuvolo Technologies Corporation offers a cloud-based enterprise asset management platform designed to support the lifecycle management of assets in various sectors, including healthcare, manufacturing, and facilities management. Founded in 2013 and headquartered in Paramus, New Jersey, Nuvolo innovates on the ServiceNow platform to provide a user-friendly experience for mobile and online users. The company’s solutions encompass implementation, support, tracking, reporting, and analytics, aimed at optimizing operational efficiency and improving asset management. Nuvolo also emphasizes security, workflow automation, and accurate inventory data, making it a comprehensive choice for businesses looking to enhance their asset management capabilities. With additional offices in London, Sofia, and Pune, Nuvolo maintains a global presence through strategic partnerships with firms such as KPMG and Unisys.

SetPoint Medical Corporation is a clinical-stage bioelectronic medicine company based in Valencia, California, focused on developing implantable neuromodulation devices for the treatment of debilitating inflammatory diseases. Established in 2006 and formerly known as Innovative Metabolics Inc., the company aims to provide innovative solutions for chronic autoimmune conditions such as rheumatoid arthritis and inflammatory bowel disease. SetPoint Medical's technology leverages vagus nerve stimulation to activate the body's natural inflammatory reflex, producing a systemic anti-inflammatory effect. This platform offers an alternative treatment option that may present lower risks and costs compared to traditional drug therapies, ultimately seeking to improve patient outcomes in managing chronic inflammatory diseases.

SomaLogic, Inc. is a commercial-stage company based in Boulder, Colorado, specializing in protein biomarker discovery and clinical diagnostics. Founded in 1999, the company has developed advanced technologies such as SOMAmers, slow off-rate modified aptamers that specifically bind to target proteins, and the SOMAscan platform, which facilitates comprehensive protein measurement. This innovative approach allows for the analysis of protein biomarker signatures, significantly enhancing the understanding of health and disease beyond traditional genomic methods. SomaLogic's products are utilized in a variety of applications, including diagnostics for conditions in oncology, neurology, and cardiovascular and metabolic diseases, as well as in drug discovery and development. The company also offers diagnostic tests and protein measurement solutions for life science and biopharma researchers, contributing to advancements in medical science.

Included Health is a healthcare company that provides a blend of virtual care, navigation, and community-based healthcare services to enhance the member experience. It combines advanced technology and a compassionate approach to deliver personalized care guidance and advocacy, ensuring that individuals receive the right care at the right time. The company's offerings include access to both virtual and in-person services for a range of healthcare needs, including urgent and primary care, behavioral health, and specialty care. By focusing on a member-centric model, Included Health aims to raise the standard of healthcare for everyone, making it simpler and more effective for individuals to navigate their health journey.

NeuroPace, Inc. is a commercial-stage medical device company based in Mountain View, California, that specializes in the treatment of neurological disorders through innovative implantable devices. Founded in 1997, NeuroPace has developed the Responsive Neurostimulator (RNS) System, which is designed to monitor and respond to brain activity in patients with medically refractory partial epilepsy. The RNS System includes a small implantable neurostimulator connected to leads placed in seizure onset areas, delivering targeted electrical pulses to help reduce or eliminate seizures. NeuroPace primarily generates revenue from the sales of its RNS System to hospitals and specialized medical facilities that perform the implantation procedures.

MISSION Therapeutics is a biotechnology company specializing in developing drugs that target the cellular process of deubiquitylation for the treatment of cancer and other diseases. Their focus is on developing small molecule drugs that selectively inhibit specific deubiquitylating enzymes (DUBs), which play crucial roles in regulating protein degradation and cellular processes. These drugs aim to intervene in disease mechanisms where DUB dysregulation is implicated, offering potential therapeutic benefits.

Evidation Health, Inc. is a California-based company that specializes in developing digital tools and technologies for healthcare data analytics. Founded in 2012, the company connects digital health firms with healthcare providers, payers, and other stakeholders through its advanced technology solutions. Its primary offerings include a data platform that transforms everyday behavior data from various sources, such as sensors and devices, into meaningful health insights, and a technology-enabled service called Studies that facilitates real-world research using this data. Evidation Health aims to enhance the understanding of how daily behaviors impact health and disease, ultimately empowering individuals to engage in better health outcomes. The company's commitment to user privacy and control over health data has garnered trust from millions of individuals, enabling them to participate in innovative health programs and research.

Genome Medical, Inc. is a genomic medicine delivery company based in South San Francisco, California, established in 2016. It operates a technology platform known as Genome Care Delivery, which connects individuals and healthcare providers with genetic specialists to facilitate virtual genetic consultations. The company focuses on various areas of clinical care, including cancer, cardiovascular health, reproductive health, pediatrics, and pharmacogenomics. By providing expert genetic assessments and personalized clinical action plans, Genome Medical helps patients understand their genetic risks and make informed treatment decisions. Additionally, the company supports healthcare providers in navigating the growing field of genetics, enhancing disease diagnosis, and improving patient care while aiming to reduce overall healthcare costs.

Arterys Inc. is a pioneering company in the field of medical imaging analytics, focused on transforming healthcare through advanced radiology solutions. Established in 2007 and headquartered in San Francisco, California, with additional offices in Calgary, Canada, and Paris, France, Arterys offers a web-based, AI-powered platform that is FDA-cleared and designed to enhance patient care. Its suite of products includes Cardio AI for cardiac magnetic resonance image analysis, Lung AI for lung imaging, Liver AI for liver imaging, and Chest/MSK AI, which automates the detection of various conditions such as fractures and pulmonary nodules. Additionally, the Arterys PHI Service allows physicians to access patient data remotely. The platform's innovative technology enables radiologists to visualize and quantify blood flow in the human body, facilitating improved diagnostic capabilities and clinical decision-making.

Syapse, Inc. is a technology company that specializes in precision medicine through its innovative software platform, which aggregates and analyzes clinical, molecular, treatment, and outcomes data. Founded in 2008 and headquartered in San Francisco, California, with an additional office in Radnor, Pennsylvania, Syapse aims to enhance healthcare by providing actionable insights that support data-driven decision-making in precision oncology. The company operates the Syapse Learning Health Network, a global network that enables health systems and life sciences collaborators to share real-world cancer data. This network empowers healthcare organizations to collaborate effectively, ensuring that oncologists and decision-makers have access to comprehensive patient insights at the point of care, ultimately driving improved outcomes for cancer patients. Syapse has established strategic partnerships, including a collaboration with Pfizer, to further its mission of delivering personalized care based on robust real-world evidence.

IntelyCare, Inc. is a healthcare staffing solutions company based in Quincy, Massachusetts, founded in 2014. It provides an advanced digital workforce augmentation platform that combines a gig-model application with data science to address staffing challenges in the healthcare sector. The platform allows post-acute healthcare facilities to optimize their staffing levels by matching nursing professionals with available shifts, thereby filling positions at a rate significantly higher than the industry average. It also empowers nurses and nursing assistants to create flexible schedules and choose their preferred shifts, helping to reduce burnout and improve retention rates. In addition, IntelyCare's platform incorporates artificial intelligence to automate scheduling and manage staffing needs efficiently, while also ensuring that healthcare providers can verify the licensure status of nursing staff easily. The company serves a diverse range of clients, including nurses, home care agencies, assisted living facilities, long-term care institutions, and rehabilitation hospitals.

Arcadia Solutions, LLC is a healthcare technology company based in Burlington, Massachusetts, specializing in electronic health record (EHR) data aggregation and analytics. Founded in 2002, Arcadia provides a suite of services and proprietary software aimed at large healthcare providers, payors, accountable care organizations, and health information exchanges. The company offers various IT services, including EHR implementation and optimization, performance management, and information security solutions. Additionally, Arcadia develops customizable tools for planning and maintaining health IT infrastructures, which include monitoring services to evaluate key performance indicators and manage technology lifecycle needs. By integrating diverse healthcare data into a unified platform, Arcadia enables organizations to derive actionable insights that enhance care, support research, and drive strategic growth while ensuring financial success.

Singular Genomics is a life science technology company that develops innovative sequencing platforms. Its core product, the Singular Sequencing Engine, powers two integrated solutions: G4 for next-generation sequencing (NGS) markets, offering high accuracy and speed; and PX, which combines single-cell analysis, spatial analysis, genomics, and proteomics in one versatile multi-omics instrument. These products aim to empower researchers and clinicians across diverse fields such as basic biology, oncology, immunology, and more.

Providence Medical Technology, Inc. is a medical device company specializing in innovative solutions for cervical spine conditions, operating in the United States and internationally. The company has developed a proprietary approach to cervical fusion, offering a range of products designed to treat cervical degenerative disc disease through indirect decompression and fusion. Its product lineup includes the DTRAX Spinal System, which comprises single-use disposable instruments for accessing the spine via posterior surgical incisions; the DTRAX Cervical Cage for treating cervical radiculopathy; the DTRAX Graft, a structural allograft for supporting posterior fusion; and the DTRAX Facet System, a sterile kit containing necessary tools and implants for single-level surgeries. Providence Medical Technology distributes its products through a network of distributors and sales representatives and is headquartered in Lafayette, California.

Headspace is a company dedicated to enhancing mental healthcare through its digital platform, which focuses on meditation, mindfulness, and overall mental well-being. The Headspace app features a diverse array of guided meditations led by experts, including its co-founder Andy Puddicombe, aimed at helping users reduce stress, improve focus, and cultivate mindfulness. It also offers specialized tools for sleep, such as "Sleepcasts," soundscapes, and guided sleep meditations, to aid users in achieving better rest. In addition to these features, Headspace provides mindfulness programs that address various aspects of daily life, including work, relationships, and health, while also focusing on managing mental health challenges like anxiety and depression. Furthermore, the company collaborates with organizations through corporate wellness programs, supplying resources designed to enhance employee productivity and well-being.

Vertos Medical Inc. is a medical device company specializing in minimally invasive treatments for lumbar spinal stenosis, a common spinal condition. Founded in 2005 and headquartered in Aliso Viejo, California, the company develops and markets its mild device, which provides an outpatient treatment option that is fluoroscopically guided and does not require implants. This device encompasses a range of instruments including tissue sculptors, surgical clamps, and bone sculpters, allowing physicians to effectively relieve pressure on the spinal nerves and restore mobility with local anesthesia. Vertos Medical’s innovative approach offers patients a less invasive option compared to traditional lumbar decompression surgeries, making significant advancements in spinal healthcare.

Prolacta Bioscience Inc. is a life science company based in Duarte, California, specializing in the development and production of human milk-based nutritional products for premature and critically ill infants in neonatal intensive care units (NICUs). Established in 1999, Prolacta is recognized for its innovative approach, being the first and only company to offer a human milk fortifier made entirely from human milk. The company's product line includes human milk fortifiers, caloric fortifiers, standardized human milk, and ready-to-feed formulas specifically designed to meet the unique nutritional needs of vulnerable infants. Prolacta operates a pharmaceutical-grade processing facility that employs patented methods to ensure the safety and quality of its products. By focusing on advancing the science of human milk, Prolacta aims to significantly improve the health outcomes of critically ill infants through its specialized formulations and commitment to research.

ClearCorrect, LLC is a manufacturer of clear aligners designed to straighten teeth without the use of metal braces. Founded in 2006 and based in Round Rock, Texas, the company produces custom, removable aligners tailored to each patient's needs based on their dentist's or orthodontist's prescription. These aligners gradually shift teeth into the desired position, providing a comfortable and discreet alternative to traditional orthodontic methods. ClearCorrect aims to offer an affordable and effective solution for teeth alignment, benefiting both patients and dental professionals. As of September 2017, ClearCorrect operates as a subsidiary of Straumann Holding AG.

Cerapedics, Inc. is an orthobiologics company specializing in the development and commercialization of innovative synthetic small peptide technologies for bone healing. Founded in 2000 and headquartered in Westminster, Colorado, with an additional office in Denver, the company offers products such as i-FACTOR, a peptide-enhanced bone graft designed to stimulate the natural healing process in orthopedic applications, and i-FACTOR+ MATRIX for surgical implantation. Cerapedics focuses on creating biomimetic solutions, specifically its proprietary small peptide molecule (P-15), aimed at improving outcomes in spinal fusion surgery and other orthopedic procedures. The company's technology strives to provide safer and more predictable bone formation compared to traditional bone growth factors.

Akili Interactive Labs, Inc., established in 2011 and headquartered in Boston, Massachusetts, specializes in developing digital medicine solutions. The company's core business involves creating video game-based technology to assess and enhance cognitive abilities. Akili's broad pipeline focuses on treating cognitive deficiencies and improving symptoms associated with various medical conditions, such as ADHD, MDD, ASD, and inflammatory diseases.

Bluesight operates as a healthcare technology company specializing in supply chain optimization for pharmaceuticals. It offers Medication Intelligence solutions that provide real-time analytics across the entire medication lifecycle, enhancing efficiency, reducing risks, and improving patient safety within hospitals. The core product is an inventory management platform that automates pharmacy kit processing and medication tracking, replacing manual processes to increase operational efficiency and medication visibility.

AcuFocus, Inc. is an ophthalmic medical device company based in Irvine, California, specializing in small aperture technologies aimed at improving near vision. Founded in 2001, the company develops and markets innovative solutions for presbyopia, including the KAMRA inlay, which helps patients restore their near vision without compromising distance vision. Additionally, AcuFocus offers the IC-8 IOL, a small aperture lens designed for cataract patients, providing a broad range of vision from near to far distances. The company also produces the AcuTarget HD, a diagnostic and surgical planning instrument that assists in the optimal treatment selection for various eye conditions such as LASIK, cataracts, and dry eye. AcuFocus distributes its products through partners across the Americas, Asia-Pacific, Europe, and the Middle East, serving both physicians and patients in the vision care market.